-
1دورية أكاديمية
المؤلفون: Schenning LCM; Department of Rheumatology and Clinical Immunology, Amsterdam Rheumatology and immunology Center, Amsterdam University Medical Centres, Amsterdam, North Holland, Netherlands., Ottevanger R; Department of Dermatology, Leiden University Medical Center, Leiden, South Holland, Netherlands., Quint KD; Department of Dermatology, Leiden University Medical Center, Leiden, South Holland, Netherlands., Tas SW; Department of Rheumatology and Clinical Immunology, Amsterdam Rheumatology and immunology Center, Amsterdam University Medical Centres, Amsterdam, North Holland, Netherlands S.W.Tas@amsterdamumc.nl.
المصدر: Annals of the rheumatic diseases [Ann Rheum Dis] 2024 Jul 15; Vol. 83 (8), pp. 1092. Date of Electronic Publication: 2024 Jul 15.
نوع المنشور: Case Reports; Letter; Journal Article
بيانات الدورية: Publisher: BMJ Country of Publication: England NLM ID: 0372355 Publication Model: Electronic Cited Medium: Internet ISSN: 1468-2060 (Electronic) Linking ISSN: 00034967 NLM ISO Abbreviation: Ann Rheum Dis Subsets: MEDLINE
مواضيع طبية MeSH: Arthritis, Rheumatoid*/complications , Arthritis, Rheumatoid*/drug therapy , Skin Neoplasms*/pathology, Humans ; Female ; Skin Ulcer/etiology ; Skin Ulcer/pathology ; Middle Aged ; Aged ; Antirheumatic Agents/therapeutic use
-
2دورية أكاديمية
المؤلفون: Sakai R; Department of Publich Health and Epidemiology, Meiji Pharmaceutical University, Kiyose, Tokyo, Japan.; Division of Rheumatology, Department of Internal Medicine, Tokyo Women's Medical University School of Medicine, Shinjuku-ku, Tokyo, Japan., Tanaka E; Division of Rheumatology, Department of Internal Medicine, Tokyo Women's Medical University School of Medicine, Shinjuku-ku, Tokyo, Japan.; Institute of Rheumatology, Tokyo Women's Medical University Hospital, Shinjuku-ku, Tokyo, Japan., Inoue E; Showa University Research Administration Center, Showa University, Shinagawa-ku, Tokyo, Japan., Harigai M; Division of Rheumatology, Department of Internal Medicine, Tokyo Women's Medical University School of Medicine, Shinjuku-ku, Tokyo, Japan harigai.masayoshi@twmu.ac.jp.; Institute of Rheumatology, Tokyo Women's Medical University Hospital, Shinjuku-ku, Tokyo, Japan.
المصدر: RMD open [RMD Open] 2024 Jun 17; Vol. 10 (2). Date of Electronic Publication: 2024 Jun 17.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: BMJ Publishing Group Country of Publication: England NLM ID: 101662038 Publication Model: Electronic Cited Medium: Internet ISSN: 2056-5933 (Electronic) Linking ISSN: 20565933 NLM ISO Abbreviation: RMD Open Subsets: MEDLINE
مواضيع طبية MeSH: Arthritis, Rheumatoid*/drug therapy , Arthritis, Rheumatoid*/complications , Antirheumatic Agents*/therapeutic use , Antirheumatic Agents*/adverse effects , Cardiovascular Diseases*/epidemiology , Cardiovascular Diseases*/etiology , Janus Kinase Inhibitors*/therapeutic use , Janus Kinase Inhibitors*/adverse effects , Methotrexate*/therapeutic use , Methotrexate*/adverse effects, Humans ; Female ; Male ; Middle Aged ; Japan/epidemiology ; Aged ; Retrospective Studies ; Longitudinal Studies ; Adult ; Incidence ; Databases, Factual ; Risk Factors ; Insurance, Health ; East Asian People
-
3دورية أكاديمية
المؤلفون: Funada M; The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan., Miyazaki Y; The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan., Nakayamada S; The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan., Sonomoto K; The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan., Kubo S; The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan.; Department of Molecular Targeted Therapies (DMTT), University of Occupational and Environmental Health, Japan, Kitakyushu, Japan., Miyagawa I; The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan., Tanaka H; The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan., Tanaka Y; The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan tanaka@med.uoeh-u.ac.jp.
المصدر: RMD open [RMD Open] 2024 Jun 12; Vol. 10 (2). Date of Electronic Publication: 2024 Jun 12.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: BMJ Publishing Group Country of Publication: England NLM ID: 101662038 Publication Model: Electronic Cited Medium: Internet ISSN: 2056-5933 (Electronic) Linking ISSN: 20565933 NLM ISO Abbreviation: RMD Open Subsets: MEDLINE
مواضيع طبية MeSH: Arthritis, Rheumatoid*/complications , Arthritis, Rheumatoid*/drug therapy , Tomography, X-Ray Computed* , Registries* , Mycobacterium Infections, Nontuberculous*/diagnosis , Mycobacterium Infections, Nontuberculous*/drug therapy , Mycobacterium Infections, Nontuberculous*/complications , Mycobacterium Infections, Nontuberculous*/etiology, Humans ; Female ; Male ; Middle Aged ; Aged ; Nontuberculous Mycobacteria ; Anti-Bacterial Agents/therapeutic use ; Treatment Outcome ; Adult ; Molecular Targeted Therapy
-
4دورية أكاديمية
المؤلفون: van de Laar CJ; Transparency in Healthcare BV, Hengelo, Netherlands c.vandelaar@tihealthcare.nl.; Erasmus School of Health Policy and Management, Erasmus Universiteit Rotterdam, Rotterdam, Zuid-Holland, Netherlands., Oude Voshaar MAH; Department of Medical Cell BioPhysics & TechMed Center, University of Twente, Enschede, Overijssel, Netherlands., Ten Klooster P; Transparency in Healthcare bv @ University of Twente, Hengelo, Netherlands.; Department of Technology, Human and Institutional Behaviour, University of Twente, Enschede, Overijssel, Netherlands., Tedjo DI; Transparency in Healthcare bv @ University of Twente, Hengelo, Netherlands., Bos R; Rheumatology, Medical Centre Leeuwarden, Leeuwarden, Fryslân, Netherlands., Jansen T; Rheumatology, VieCuri Medical Centre, Venlo, Limburg, Netherlands., Willemze A; Department of Rheumatology and Clinical Immunology, Maasstad Hospital, Rotterdam, Netherlands., Versteeg GA; Rheumatology, Deventer Hospital, Deventer, Overijssel, Netherlands., Goekoop-Ruiterman YPM; Rheumatology, HagaZiekenhuis, Den Haag, Zuid-Holland, Netherlands., Kroot EJ; Rheumatology, Elkerliek Hospital, Helmond, Netherlands., van de Laar M; Transparency in Healthcare bv @ University of Twente, Hengelo, Netherlands.; Department of Technology, Human and Institutional Behaviour, University of Twente, Enschede, Overijssel, Netherlands.
المصدر: RMD open [RMD Open] 2024 May 30; Vol. 10 (2). Date of Electronic Publication: 2024 May 30.
نوع المنشور: Journal Article; Multicenter Study; Randomized Controlled Trial; Pragmatic Clinical Trial; Comparative Study
بيانات الدورية: Publisher: BMJ Publishing Group Country of Publication: England NLM ID: 101662038 Publication Model: Electronic Cited Medium: Internet ISSN: 2056-5933 (Electronic) Linking ISSN: 20565933 NLM ISO Abbreviation: RMD Open Subsets: MEDLINE
مواضيع طبية MeSH: Purines*/administration & dosage , Purines*/therapeutic use , Sulfonamides*/therapeutic use , Sulfonamides*/administration & dosage , Arthritis, Rheumatoid*/drug therapy , Arthritis, Rheumatoid*/complications , Pyrazoles*/therapeutic use , Pyrazoles*/administration & dosage , Pyrazoles*/adverse effects , Azetidines*/therapeutic use , Azetidines*/administration & dosage , Azetidines*/adverse effects , Antirheumatic Agents*/therapeutic use , Antirheumatic Agents*/administration & dosage, Humans ; Male ; Female ; Middle Aged ; Aged ; Treatment Outcome ; Tumor Necrosis Factor Inhibitors/therapeutic use ; Tumor Necrosis Factor Inhibitors/administration & dosage ; Tumor Necrosis Factor Inhibitors/adverse effects ; Treatment Failure ; Adult ; Patient Reported Outcome Measures ; Severity of Illness Index
-
5دورية أكاديمية
عنوان ترانسليتريتد: Polyarthrite rhumatoïde.
المؤلفون: Devauchelle-Pensec V; Service de rhumatologie, CHU de Brest, Brest, France., Ghellec D; Service de rhumatologie, CHU de Brest, Brest, France.
المصدر: La Revue du praticien [Rev Prat] 2024 May; Vol. 74 (5), pp. 561-571.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: J.-B. Baillière Country of Publication: France NLM ID: 0404334 Publication Model: Print Cited Medium: Internet ISSN: 2101-017X (Electronic) Linking ISSN: 00352640 NLM ISO Abbreviation: Rev Prat Subsets: MEDLINE
مواضيع طبية MeSH: Arthritis, Rheumatoid*/diagnosis , Arthritis, Rheumatoid*/complications, Humans ; Antirheumatic Agents/therapeutic use
-
6دورية أكاديمية
المؤلفون: Braga GC; Medical School, Federal University of Fronteira Sul, Chapecó, SC, Brazil., Simões JLB; Medical School, Federal University of Fronteira Sul, Chapecó, SC, Brazil., Teixeira Dos Santos YJ; Medical School, Federal University of Fronteira Sul, Chapecó, SC, Brazil., Filho JCM; Medical School, Federal University of Fronteira Sul, Chapecó, SC, Brazil., Bagatini MD; Graduate Program in Medical Sciences, Federal University of Fronteira Sul, Chapecó, SC, Brazil. Electronic address: margaretebagatini@yahoo.com.br.
المصدر: International immunopharmacology [Int Immunopharmacol] 2024 Jul 30; Vol. 136, pp. 112357. Date of Electronic Publication: 2024 May 27.
نوع المنشور: Journal Article; Review
بيانات الدورية: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 100965259 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-1705 (Electronic) Linking ISSN: 15675769 NLM ISO Abbreviation: Int Immunopharmacol Subsets: MEDLINE
-
7دورية أكاديمية
المؤلفون: He J; Department of Rheumatism and Immunology, Peking University Shenzhen Hospital, Shenzhen Peking University-The Hong Kong University of Science and Technology Medical Center, Shenzhen Key Laboratory of Inflammatory and Immunology Diseases, Shenzhen 518036, China., Lin X; Department of Rheumatism and Immunology, Peking University Shenzhen Hospital, Shenzhen Peking University-The Hong Kong University of Science and Technology Medical Center, Shenzhen Key Laboratory of Inflammatory and Immunology Diseases, Shenzhen 518036, China., Gao X; Department of Rheumatism and Immunology, Peking University Shenzhen Hospital, Shenzhen Peking University-The Hong Kong University of Science and Technology Medical Center, Shenzhen Key Laboratory of Inflammatory and Immunology Diseases, Shenzhen 518036, China., Luan H; Department of Rheumatism and Immunology, Peking University Shenzhen Hospital, Shenzhen Peking University-The Hong Kong University of Science and Technology Medical Center, Shenzhen Key Laboratory of Inflammatory and Immunology Diseases, Shenzhen 518036, China., Guo Y; Guangdong Provincial Key Laboratory of Research and Development of Natural Drugs; The First Dongguan Affiliated Hospital and School of Pharmacy, Guangdong Medical University, Dongguan 523808, China., Wang X; Department of Rheumatism and Immunology, Peking University Shenzhen Hospital, Shenzhen Peking University-The Hong Kong University of Science and Technology Medical Center, Shenzhen Key Laboratory of Inflammatory and Immunology Diseases, Shenzhen 518036, China., Tao C; Guangdong Provincial Key Laboratory of Research and Development of Natural Drugs; The First Dongguan Affiliated Hospital and School of Pharmacy, Guangdong Medical University, Dongguan 523808, China. Electronic address: taocheng@gdmu.edu.cn., Wang Q; Department of Rheumatism and Immunology, Peking University Shenzhen Hospital, Shenzhen Peking University-The Hong Kong University of Science and Technology Medical Center, Shenzhen Key Laboratory of Inflammatory and Immunology Diseases, Shenzhen 518036, China. Electronic address: wangqingwen@pkuszh.com., Chen J; Department of Rheumatism and Immunology, Peking University Shenzhen Hospital, Shenzhen Peking University-The Hong Kong University of Science and Technology Medical Center, Shenzhen Key Laboratory of Inflammatory and Immunology Diseases, Shenzhen 518036, China. Electronic address: chenjian@pkuszh.com.
المصدر: International immunopharmacology [Int Immunopharmacol] 2024 Jul 30; Vol. 136, pp. 112264. Date of Electronic Publication: 2024 May 28.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 100965259 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-1705 (Electronic) Linking ISSN: 15675769 NLM ISO Abbreviation: Int Immunopharmacol Subsets: MEDLINE
مواضيع طبية MeSH: Dendritic Cells*/drug effects , Dendritic Cells*/immunology , Receptors, CCR5*/metabolism , Arthritis, Experimental*/drug therapy , Arthritis, Experimental*/immunology , Chemotaxis*/drug effects , Artesunate*/pharmacology , Artesunate*/therapeutic use , Arthritis, Rheumatoid*/drug therapy , Arthritis, Rheumatoid*/immunology, Animals ; Mice ; Mice, Inbred DBA ; Male ; Cells, Cultured ; Humans
-
8دورية أكاديمية
المؤلفون: Samarpita S; Immunopathology Lab, School of Biosciences and Technology, Vellore Institute of Technology (VIT), Vellore 632 014, Tamil Nadu, India; Department of Internal Medicine, Mayo Clinic, Rochester, MN 55905, USA; Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN 55905, USA., Srivastava S; Immunopathology Lab, School of Biosciences and Technology, Vellore Institute of Technology (VIT), Vellore 632 014, Tamil Nadu, India., Srikanth M; Immunopathology Lab, School of Biosciences and Technology, Vellore Institute of Technology (VIT), Vellore 632 014, Tamil Nadu, India., Miriam Jose A; Immunopathology Lab, School of Biosciences and Technology, Vellore Institute of Technology (VIT), Vellore 632 014, Tamil Nadu, India., Rithvik A; Immunopathology Lab, School of Biosciences and Technology, Vellore Institute of Technology (VIT), Vellore 632 014, Tamil Nadu, India., Rasool M; Immunopathology Lab, School of Biosciences and Technology, Vellore Institute of Technology (VIT), Vellore 632 014, Tamil Nadu, India. Electronic address: mkr474@gmail.com.
المصدر: International immunopharmacology [Int Immunopharmacol] 2024 Jul 30; Vol. 136, pp. 112343. Date of Electronic Publication: 2024 May 28.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 100965259 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-1705 (Electronic) Linking ISSN: 15675769 NLM ISO Abbreviation: Int Immunopharmacol Subsets: MEDLINE
مواضيع طبية MeSH: Interleukin-17*/metabolism , STAT3 Transcription Factor*/metabolism , Arthritis, Rheumatoid*/immunology , Arthritis, Rheumatoid*/metabolism , Arthritis, Rheumatoid*/drug therapy , Macrophages*/immunology , Macrophages*/metabolism , Macrophages*/drug effects , Signal Transduction* , B7-H1 Antigen*/metabolism , Receptors, Interleukin-17*/metabolism , Receptors, Interleukin-17*/genetics, Animals ; Mice ; Anthocyanins/pharmacology ; Arthritis, Experimental/immunology ; Humans ; Disease Models, Animal ; Phagocytosis/drug effects ; Male ; Synovial Membrane/immunology ; Synovial Membrane/pathology ; Mice, Inbred C57BL ; Apoptosis/drug effects ; Efferocytosis
-
9دورية أكاديمية
المؤلفون: Liu L; Institute of Urology, The Affiliated Luohu Hospital of Shenzhen University, Shenzhen University, Shenzhen, 518000, China., Deng D; Institute of Urology, The Affiliated Luohu Hospital of Shenzhen University, Shenzhen University, Shenzhen, 518000, China., Li C; Institute of Urology, The Affiliated Luohu Hospital of Shenzhen University, Shenzhen University, Shenzhen, 518000, China., Huang G; Institute of Urology, The Affiliated Luohu Hospital of Shenzhen University, Shenzhen University, Shenzhen, 518000, China., Zhang W; Institute of Urology, The Affiliated Luohu Hospital of Shenzhen University, Shenzhen University, Shenzhen, 518000, China., Liang T; Institute of Urology, The Affiliated Luohu Hospital of Shenzhen University, Shenzhen University, Shenzhen, 518000, China., Liang R; Institute of Urology, The Affiliated Luohu Hospital of Shenzhen University, Shenzhen University, Shenzhen, 518000, China., Liang M; Institute of Urology, The Affiliated Luohu Hospital of Shenzhen University, Shenzhen University, Shenzhen, 518000, China., Su Y; Institute of Urology, The Affiliated Luohu Hospital of Shenzhen University, Shenzhen University, Shenzhen, 518000, China., Lin C; Institute of Urology, The Affiliated Luohu Hospital of Shenzhen University, Shenzhen University, Shenzhen, 518000, China., Li G; Institute of Urology, The Affiliated Luohu Hospital of Shenzhen University, Shenzhen University, Shenzhen, 518000, China. guangzhili@email.szu.edu., Wu S; Institute of Urology, The Affiliated Luohu Hospital of Shenzhen University, Shenzhen University, Shenzhen, 518000, China. wusong@szu.edu.cn.; Institute of Urology, South China Hospital, Health Science Center, Shenzhen University, Shenzhen, 518116, China. wusong@szu.edu.cn.
المصدر: Journal of nanobiotechnology [J Nanobiotechnology] 2024 Jul 22; Vol. 22 (1), pp. 432. Date of Electronic Publication: 2024 Jul 22.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101152208 Publication Model: Electronic Cited Medium: Internet ISSN: 1477-3155 (Electronic) Linking ISSN: 14773155 NLM ISO Abbreviation: J Nanobiotechnology Subsets: MEDLINE
مواضيع طبية MeSH: Melitten*/pharmacology , Melitten*/chemistry , Arthritis, Rheumatoid*/therapy , Arthritis, Rheumatoid*/drug therapy , Hydrogels*/chemistry , Needles* , Acupuncture Therapy*/methods, Animals ; Mice ; Chitosan/chemistry ; Hyaluronic Acid/chemistry ; Male ; Disease Models, Animal ; Mice, Inbred C57BL
-
10دورية أكاديمية
المؤلفون: Heutz JW; Department of Rheumatology, Erasmus Medical Center, Rotterdam, Netherlands j.heutz@erasmusmc.nl., Looijen AEM; Department of Rheumatology, Erasmus Medical Center, Rotterdam, Netherlands., van der Helm-van Mil AHM; Department of Rheumatology, Erasmus Medical Center, Rotterdam, Netherlands.; Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands., de Jong PHP; Department of Rheumatology, Erasmus Medical Center, Rotterdam, Netherlands., van Mulligen E; Department of Rheumatology, Erasmus Medical Center, Rotterdam, Netherlands.; Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands.
المصدر: RMD open [RMD Open] 2024 Jul 20; Vol. 10 (3). Date of Electronic Publication: 2024 Jul 20.
نوع المنشور: Journal Article; Letter
بيانات الدورية: Publisher: BMJ Publishing Group Country of Publication: England NLM ID: 101662038 Publication Model: Electronic Cited Medium: Internet ISSN: 2056-5933 (Electronic) Linking ISSN: 20565933 NLM ISO Abbreviation: RMD Open Subsets: MEDLINE
مواضيع طبية MeSH: Arthritis, Rheumatoid*/immunology , Anti-Citrullinated Protein Antibodies*/blood, Humans ; Antirheumatic Agents/therapeutic use ; Antirheumatic Agents/administration & dosage ; Tumor Necrosis Factor Inhibitors/therapeutic use ; Tumor Necrosis Factor Inhibitors/adverse effects ; Tumor Necrosis Factor Inhibitors/administration & dosage ; Female